Sverige - svenska - Läkemedelsverket (Medical Products Agency)

glenmark arzneimittel gmbh - mometasonfuroatmonohydrat - nässpray, suspension - 50 mikrogram/dos - mometasonfuroatmonohydrat 51,73 mikrog aktiv substans; etanol, vattenfri hjälpämne; bensalkoniumklorid hjälpämne; glycerol hjälpämne - mometason

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

orifarm ab - mometasonfuroatmonohydrat - nässpray, suspension - 50 mikrogram/dos - glycerol hjälpämne; bensalkoniumklorid hjälpämne; mometasonfuroatmonohydrat 52 mikrog aktiv substans

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

orifarm generics a/s - mometasonfuroatmonohydrat - nässpray, suspension - 50 mikrogram/dos - glycerol hjälpämne; mometasonfuroatmonohydrat 52 mikrog aktiv substans; bensalkoniumklorid hjälpämne

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

2care4 generics aps - mometasonfuroatmonohydrat - nässpray, suspension - 50 mikrogram/dos - mometasonfuroatmonohydrat 52 mikrog aktiv substans; bensalkoniumklorid hjälpämne; glycerol 85% hjälpämne

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

ebb medical ab - mometasonfuroatmonohydrat - nässpray, suspension - 50 mikrogram/dos - glycerol hjälpämne; mometasonfuroatmonohydrat 52 mikrog aktiv substans; bensalkoniumklorid hjälpämne

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

ebb medical ab - mometasonfuroatmonohydrat - nässpray, suspension - 50 mikrogram/dos - mometasonfuroatmonohydrat 52 mikrog aktiv substans; bensalkoniumklorid hjälpämne; glycerol hjälpämne

Europeiska unionen - svenska - EMA (European Medicines Agency)

novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - läkemedel mot obstruktiv lungsjukdom, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

Europeiska unionen - svenska - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol, mometasone furoate - astma - läkemedel mot obstruktiv lungsjukdom, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Europeiska unionen - svenska - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol acetate, mometasone furoate - astma - läkemedel mot obstruktiv lungsjukdom, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Europeiska unionen - svenska - EMA (European Medicines Agency)

novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - läkemedel mot obstruktiv lungsjukdom, - maintenance treatment of asthma in adults whose disease is not adequately controlled.